Goldman Sachs Group Inc Bristol Myers Squibb CO Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $84.9 Million - $111 Million	-2,140,500 Reduced 72.43%	814,700 $42.2 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $13.4 Million - $17.6 Million	-332,700 Reduced 10.12%	2,955,200 $123 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $15.4 Million - $17.4 Million	320,700 Added 10.81%	3,287,900 $178 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $110 Million - $131 Million	2,266,500 Added 323.46%	2,967,200 $152 Million
Q3 2023 May 14, 2024	SELL	$57.89 - $64.73 $131 Million - $147 Million	-2,266,500 Reduced 76.39%	700,700 $40.7 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $31.2 Million - $34.8 Million	538,300 Added 331.47%	700,700 $40.7 Million
Q2 2023 May 14, 2024	BUY	$63.71 - $70.74 $6.91 Million - $7.67 Million	108,400 Added 200.74%	162,400 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $6.91 Million - $7.67 Million	108,400 Added 200.74%	162,400 $10.4 Million
Q1 2023 May 14, 2024	SELL	$65.71 - $74.53 $14.2 Million - $16.2 Million	-216,700 Reduced 80.05%	54,000 $3.74 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $14.2 Million - $16.2 Million	-216,700 Reduced 80.05%	54,000 $3.74 Million
Q4 2022 May 14, 2024	BUY	$68.48 - $81.09 $5.54 Million - $6.56 Million	80,900 Added 42.62%	270,700 $19.5 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $5.54 Million - $6.56 Million	80,900 Added 42.62%	270,700 $19.5 Million
Q3 2022 May 14, 2024	SELL	$0.13 - $76.84 $13,611 - $8.05 Million	-104,700 Reduced 35.55%	189,800 $13.5 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $13,611 - $8.05 Million	-104,700 Reduced 35.55%	189,800 $13.5 Million
Q2 2022 May 14, 2024	SELL	$72.62 - $79.98 $194 Million - $214 Million	-2,672,700 Reduced 90.07%	294,500 $22.7 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $11.9 Million - $13.1 Million	163,600 Added 124.98%	294,500 $22.7 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $23.8 Million - $28.5 Million	-387,000 Reduced 74.72%	130,900 $9.56 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $10.9 Million - $12.7 Million	203,200 Added 64.57%	517,900 $32.3 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $18.6 Million - $21.8 Million	314,700 New	314,700 $18.6 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.3 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.51 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.57 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.67 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.66 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $127B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account